133 related articles for article (PubMed ID: 38290783)
1. Neuroendocrine neoplasms of the ovary: a review of 63 cases.
Flores Legarreta A; Saab R; Gonzales NR; Chisholm GB; Westin SN; Hillman RT; Frumovitz M
Int J Gynecol Cancer; 2024 Apr; 34(4):566-573. PubMed ID: 38290783
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading.
Huang W; Bao Y; Luo X; Yao L; Yuan L
Endocrine; 2022 Jun; 77(1):188-198. PubMed ID: 35538309
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
Salvo G; Flores Legarreta A; Ramalingam P; Jhingran A; Bhosale P; Saab R; Gonzales NR; Chisholm GB; Frumovitz M
Int J Gynecol Cancer; 2023 Sep; 33(9):1359-1369. PubMed ID: 37567596
[TBL] [Abstract][Full Text] [Related]
4. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
5. Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features.
Feng BJ; Li TH; Li YH; Feng JX; Zhang J; Ma JY; Wang YW; Lu SS
BMC Womens Health; 2023 Nov; 23(1):595. PubMed ID: 37953251
[TBL] [Abstract][Full Text] [Related]
6. Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study.
Albores-Saavedra J; Hart A; Chablé-Montero F; Henson DE
Arch Pathol Lab Med; 2010 Nov; 134(11):1692-6. PubMed ID: 21043824
[TBL] [Abstract][Full Text] [Related]
7. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors of the ovary--a review.
Kupryjańczyk J
Verh Dtsch Ges Pathol; 1997; 81():253-9. PubMed ID: 9474878
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
[TBL] [Abstract][Full Text] [Related]
10. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine carcinoma of ovary: Hitherto rare entity in primary ovarian tumors.
Osama MA; Rao S; Bhardwaj P; Mediratta G; Bhalla S; Badwal S
Indian J Pathol Microbiol; 2023; 66(4):855-858. PubMed ID: 38084548
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation.
Vora M; Lacour RA; Black DR; Turbat-Herrera EA; Gu X
Arch Gynecol Obstet; 2016 Mar; 293(3):659-65. PubMed ID: 26306985
[TBL] [Abstract][Full Text] [Related]
13. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T
Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence.
Broaddus RR; Herzog CE; Hicks MJ
Arch Pathol Lab Med; 2003 Sep; 127(9):1200-3. PubMed ID: 12946222
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.
Lee PC; Osakwe NC; Narula N; Port JL; Paul S; Stiles BM; Andrews WG; Nasar A; Altorki NK
Thorac Cardiovasc Surg; 2016 Mar; 64(2):159-65. PubMed ID: 25756243
[TBL] [Abstract][Full Text] [Related]
17. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
18. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
20. Primary neuroendocrine tumors of ovary: A clinicopathological spectrum in a tertiary care hospital with review of literature.
Kushwaha P; Mandal S; Mallya V; Khurana N; Ghandhi G; Singh K
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S623-S627. PubMed ID: 38384029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
